Literature DB >> 23774992

Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model.

Gillian S Dite1, Maryam Mahmoodi, Adrian Bickerstaffe, Fleur Hammet, Robert J Macinnis, Helen Tsimiklis, James G Dowty, Carmel Apicella, Kelly-Anne Phillips, Graham G Giles, Melissa C Southey, John L Hopper.   

Abstract

It has been shown that, for women aged 50 years or older, the discriminatory accuracy of the Breast Cancer Risk Prediction Tool (BCRAT) can be modestly improved by the inclusion of information on common single nucleotide polymorphisms (SNPs) that are associated with increased breast cancer risk. We aimed to determine whether a similar improvement is seen for earlier onset disease. We used the Australian Breast Cancer Family Registry to study a population-based sample of 962 cases aged 35-59 years, and 463 controls frequency matched for age and for whom genotyping data was available. Overall, the inclusion of data on seven SNPs improved the area under the receiver operating characteristic curve (AUC) from 0.58 (95 % confidence interval [CI] 0.55-0.61) for BCRAT alone to 0.61 (95 % CI 0.58-0.64) for BCRAT and SNP data combined (p < 0.001). For women aged 35-39 years at interview, the corresponding improvement in AUC was from 0.61 (95 % CI 0.56-0.66) to 0.65 (95 % CI 0.60-0.70; p = 0.03), while for women aged 40-49 years at diagnosis, the AUC improved from 0.61 (95 % CI 0.55-0.66) to 0.63 (95 % CI 0.57-0.69; p = 0.04). Using previously used classifications of low, intermediate and high risk, 2.1 % of cases and none of the controls aged 35-39 years, and 10.9 % of cases and 4.0 % of controls aged 40-49 years were classified into a higher risk group. Including information on seven SNPs associated with breast cancer risk, improves the discriminatory accuracy of BCRAT for women aged 35-39 years and 40-49 years. Given, the low absolute risk for women in these age groups, only a small proportion are reclassified into a higher category for predicted 5-year risk of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23774992      PMCID: PMC4059776          DOI: 10.1007/s10549-013-2610-2

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  17 in total

1.  Comparing breast cancer risk assessment models.

Authors:  Mitchell H Gail; Phuong L Mai
Journal:  J Natl Cancer Inst       Date:  2010-04-28       Impact factor: 13.506

2.  Prospective breast cancer risk prediction model for women undergoing screening mammography.

Authors:  William E Barlow; Emily White; Rachel Ballard-Barbash; Pamela M Vacek; Linda Titus-Ernstoff; Patricia A Carney; Jeffrey A Tice; Diana S M Buist; Berta M Geller; Robert Rosenberg; Bonnie C Yankaskas; Karla Kerlikowske
Journal:  J Natl Cancer Inst       Date:  2006-09-06       Impact factor: 13.506

3.  Breast cancer in Australian women under the age of 40.

Authors:  M R McCredie; G S Dite; G G Giles; J L Hopper
Journal:  Cancer Causes Control       Date:  1998-03       Impact factor: 2.506

4.  Validation studies for models projecting the risk of invasive and total breast cancer incidence.

Authors:  J P Costantino; M H Gail; D Pee; S Anderson; C K Redmond; J Benichou; H S Wieand
Journal:  J Natl Cancer Inst       Date:  1999-09-15       Impact factor: 13.506

Review 5.  Assessing women at high risk of breast cancer: a review of risk assessment models.

Authors:  Eitan Amir; Orit C Freedman; Bostjan Seruga; D Gareth Evans
Journal:  J Natl Cancer Inst       Date:  2010-04-28       Impact factor: 13.506

6.  Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS).

Authors:  J L Hopper; G Chenevix-Trench; D J Jolley; G S Dite; M A Jenkins; D J Venter; M R McCredie; G G Giles
Journal:  J Natl Cancer Inst Monogr       Date:  1999

7.  Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density.

Authors:  Jinbo Chen; David Pee; Rajeev Ayyagari; Barry Graubard; Catherine Schairer; Celia Byrne; Jacques Benichou; Mitchell H Gail
Journal:  J Natl Cancer Inst       Date:  2006-09-06       Impact factor: 13.506

8.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.

Authors:  M H Gail; L A Brinton; D P Byar; D K Corle; S B Green; C Schairer; J J Mulvihill
Journal:  J Natl Cancer Inst       Date:  1989-12-20       Impact factor: 13.506

9.  Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women.

Authors:  E Comen; L Balistreri; M Gönen; A Dutra-Clarke; M Fazio; J Vijai; Z Stadler; N Kauff; T Kirchhoff; C Hudis; K Offit; M Robson
Journal:  Breast Cancer Res Treat       Date:  2010-10-19       Impact factor: 4.872

10.  Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations.

Authors:  Gillian S Dite; Mark A Jenkins; Melissa C Southey; Jane S Hocking; Graham G Giles; Margaret R E McCredie; Deon J Venter; John L Hopper
Journal:  J Natl Cancer Inst       Date:  2003-03-19       Impact factor: 13.506

View more
  19 in total

Review 1.  Suitable trial designs and cohorts for preventive breast cancer agents.

Authors:  Kathrin Strasser-Weippl; Paul E Goss
Journal:  Nat Rev Clin Oncol       Date:  2013-10-08       Impact factor: 66.675

2.  Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry.

Authors:  Gillian S Dite; Robert J MacInnis; Adrian Bickerstaffe; James G Dowty; Richard Allman; Carmel Apicella; Roger L Milne; Helen Tsimiklis; Kelly-Anne Phillips; Graham G Giles; Mary Beth Terry; Melissa C Southey; John L Hopper
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-12-16       Impact factor: 4.254

Review 3.  Risk determination and prevention of breast cancer.

Authors:  Anthony Howell; Annie S Anderson; Robert B Clarke; Stephen W Duffy; D Gareth Evans; Montserat Garcia-Closas; Andy J Gescher; Timothy J Key; John M Saxton; Michelle N Harvie
Journal:  Breast Cancer Res       Date:  2014-09-28       Impact factor: 6.466

4.  Associations between breast density and a panel of single nucleotide polymorphisms linked to breast cancer risk: a cohort study with digital mammography.

Authors:  Brad M Keller; Anne Marie McCarthy; Jinbo Chen; Katrina Armstrong; Emily F Conant; Susan M Domchek; Despina Kontos
Journal:  BMC Cancer       Date:  2015-03-18       Impact factor: 4.430

5.  The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.

Authors:  Anne Marie McCarthy; Brad Keller; Despina Kontos; Leigh Boghossian; Erin McGuire; Mirar Bristol; Jinbo Chen; Susan Domchek; Katrina Armstrong
Journal:  Breast Cancer Res       Date:  2015-01-08       Impact factor: 6.466

6.  A Prediction Algorithm for Drug Response in Patients with Mesial Temporal Lobe Epilepsy Based on Clinical and Genetic Information.

Authors:  Mariana S Silva-Alves; Rodrigo Secolin; Benilton S Carvalho; Clarissa L Yasuda; Elizabeth Bilevicius; Marina K M Alvim; Renato O Santos; Claudia V Maurer-Morelli; Fernando Cendes; Iscia Lopes-Cendes
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

7.  Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis.

Authors:  Xin Wang; Yubei Huang; Lian Li; Hongji Dai; Fengju Song; Kexin Chen
Journal:  Breast Cancer Res       Date:  2018-03-13       Impact factor: 6.466

8.  SNPs and breast cancer risk prediction for African American and Hispanic women.

Authors:  Richard Allman; Gillian S Dite; John L Hopper; Ora Gordon; Athena Starlard-Davenport; Rowan Chlebowski; Charles Kooperberg
Journal:  Breast Cancer Res Treat       Date:  2015-11-20       Impact factor: 4.872

Review 9.  Improved prediction of complex diseases by common genetic markers: state of the art and further perspectives.

Authors:  Bent Müller; Arndt Wilcke; Anne-Laure Boulesteix; Jens Brauer; Eberhard Passarge; Johannes Boltze; Holger Kirsten
Journal:  Hum Genet       Date:  2016-02-02       Impact factor: 4.132

Review 10.  Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.

Authors:  Suzanne A Eccles; Eric O Aboagye; Simak Ali; Annie S Anderson; Jo Armes; Fedor Berditchevski; Jeremy P Blaydes; Keith Brennan; Nicola J Brown; Helen E Bryant; Nigel J Bundred; Joy M Burchell; Anna M Campbell; Jason S Carroll; Robert B Clarke; Charlotte E Coles; Gary J R Cook; Angela Cox; Nicola J Curtin; Lodewijk V Dekker; Isabel dos Santos Silva; Stephen W Duffy; Douglas F Easton; Diana M Eccles; Dylan R Edwards; Joanne Edwards; D Evans; Deborah F Fenlon; James M Flanagan; Claire Foster; William M Gallagher; Montserrat Garcia-Closas; Julia M W Gee; Andy J Gescher; Vicky Goh; Ashley M Groves; Amanda J Harvey; Michelle Harvie; Bryan T Hennessy; Stephen Hiscox; Ingunn Holen; Sacha J Howell; Anthony Howell; Gill Hubbard; Nick Hulbert-Williams; Myra S Hunter; Bharat Jasani; Louise J Jones; Timothy J Key; Cliona C Kirwan; Anthony Kong; Ian H Kunkler; Simon P Langdon; Martin O Leach; David J Mann; John F Marshall; Lesley Martin; Stewart G Martin; Jennifer E Macdougall; David W Miles; William R Miller; Joanna R Morris; Sue M Moss; Paul Mullan; Rachel Natrajan; James P B O'Connor; Rosemary O'Connor; Carlo Palmieri; Paul D P Pharoah; Emad A Rakha; Elizabeth Reed; Simon P Robinson; Erik Sahai; John M Saxton; Peter Schmid; Matthew J Smalley; Valerie Speirs; Robert Stein; John Stingl; Charles H Streuli; Andrew N J Tutt; Galina Velikova; Rosemary A Walker; Christine J Watson; Kaye J Williams; Leonie S Young; Alastair M Thompson
Journal:  Breast Cancer Res       Date:  2013-10-01       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.